Stay updated with breaking news from Michael Secora. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CFO Michael Secora sold 25,000 shares of the business’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $10.45, for a total transaction of $261,250.00. Following the sale, the chief financial officer now directly owns 968,514 shares of the […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CFO Michael Secora sold 25,000 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $6.32, for a total value of $158,000.00. Following the transaction, the chief financial officer now owns 925,686 shares of the company’s […]
In a notable insider transaction, CFO Michael Secora of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) sold 50,000 shares of the company's stock on November 15, 2023.